Is Talis Biomedical Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Talis Biomedical Corp (TLIS) is currently classified as NOT HALAL as of October 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Talis Biomedical Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Talis Biomedical Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Talis Biomedical Corp?

Muslim investors may consider investing in Talis Biomedical Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Talis Biomedical Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Talis Biomedical Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Talis Biomedical Corp updated?

The Shariah compliance status of Talis Biomedical Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Talis Biomedical Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Talis Biomedical Corp?

You can check the latest Shariah compliance status of Talis Biomedical Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

TLIS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 17, 2024

Report Source: 2024 2nd Quarter Report

Analyst's Ratings for Talis Biomedical Corp (TLIS)

Based on 6 analysts giving stock ratings to Talis Biomedical Corp in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Talis Biomedical Corp. Stock Analysis TLIS

United States Health Care Micro Cap Report: Q2, 2024

Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company is headquartered in Chicago, Illinois and currently employs 99 full-time employees. The company went IPO on 2021-02-12. The firm is focused on advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care.

Key Statistics of Talis Biomedical Corp (TLIS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.80$2.84

Today's Open

$2.80

Volume

59.31K

P/E Ratio (TTM)

52 Week Range

$1.04$2.84

Market Cap

50.70M

Avg. Volume

2926.00

Dividend Yield

Financial Metrics & Statements of Talis Biomedical Corp (TLIS)

FAQ's for Talis Biomedical Corp (TLIS)

According to Musaffa’s Shariah screening methodology, Talis Biomedical Corp (TLIS) is currently classified as NOT HALAL as of October 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.